US Begins Study On Allergic Reaction Risk In Moderna, Pfizer Vaccines
The US National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.
No comments:
Post a Comment